Why Key Account Management Matters for a Successful Pharma Product Launch

Before approval, teams can build an account-level picture of clinical pathways, patient populations, access requirements, stakeholder priorities, and competitive dynamics.

This information can influence launch assumptions and help identify risks before they become execution problems.

Launch: Coordinate engagement

During launch, the goal is consistency.

Commercial representatives, medical teams, market-access professionals, and digital channels should understand the account strategy and their respective roles.

This does not mean every stakeholder receives the same message. It means interactions should reinforce a coherent value proposition while respecting each function's responsibilities and compliance requirements.

Post-launch: Adapt to evidence

Account plans should evolve once real market feedback becomes available.

A health system that initially appeared difficult to access may become more receptive after additional evidence is generated. Conversely, an account that looked attractive during planning may develop new barriers.

KAM should therefore function as an ongoing commercial capability rather than a one-time launch project.

Common KAM Mistakes During Launch

One common mistake is treating account size as the only measure of importance.